|
新聞出版品
心血管藥物新聞
Cardiovascular Drug News
|
心血管藥物新聞 是由出版商Espicom Business Intelligence在Issues / Year: 12所出版的。
這份英文新聞出版品價格從美金1025起跳。
| |
創新主流商業資訊為藥商執行長預備的服務
對製藥產業而言， 研發利潤不曾比短線炒作投機生意來得經濟效益高。 以研發為主體的公司 期真正競爭的也都是患者的利益。
CNS 在眾多發展全球心血管藥品市場的廠商、商品、疾病、與研究當中任重道遠。與主 要題材來源合作，匯集Espicom獨一無二的檔案資料，CNS Drug News 為您提供具說服力， 簡明易懂的途徑來開闢市場。
每期單行本內容包含：
以下標題將在每月論述(依版面而定)：
- 心律失常/心衰竭
- 抗高血壓藥
- 循環失調凝血
- 抗凝血劑/抗血栓症
- Hypolipidaemic Agents
- 貧血/中性白血球症
|
 |
A major new business intelligence service for pharmaceutical executives
For the pharmaceutical industry, research interest has never been higher as the hunt for blockbuster products that offer truly improved economic outcomes and real patient benefits is contested by nearly every major research-based company.
Cardiovascular Drug News takes the hard work out of staying in touch with the companies, products, alliances and research that are shaping the global cardiovascular drug markets. Incorporating primary source material augmented with data from Espicom's unique intelligence database, Cardiovascular Drug News provides a compelling, easy-to-read route to complete market knowledge.
The following sections will appear in every issue:
- General Development News
- International Conference Listings
A selection of the following topics will appear each month, depending on news availability:
- Arrhythmias/Cardiac Failure
- Antihypertensives
- Circulatory Disorders
- Anticoagulants/Antithrombotics & Fibrinolytics
- Haemostatics
- Hypolipidaemic Agents
- Anaemia & Neutropenia
|
|
